409 related articles for article (PubMed ID: 29962814)
21. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
Peng C; Huang K; Liu G; Li Y; Yu C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1711-1719. PubMed ID: 30843262
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA PLEC acts as a sponge of microRNA-198 to promote gastric carcinoma cell resistance to paclitaxel and tumorigenesis.
Zhou N; Wang W; Xu C; Yu W
Pathol Res Pract; 2021 Aug; 224():153487. PubMed ID: 34225215
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
[TBL] [Abstract][Full Text] [Related]
25. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
26. Tumor initiating potential of side population cells in human gastric cancer.
Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.
Soleimani A; Dadjoo P; Avan A; Soleimanpour S; Rajabian M; Ferns G; Ryzhikov M; Khazaei M; Hassanian SM
Life Sci; 2022 Mar; 293():120050. PubMed ID: 35026215
[TBL] [Abstract][Full Text] [Related]
28. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
29. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
[TBL] [Abstract][Full Text] [Related]
30. The stabilization of yes-associated protein by TGFβ-activated kinase 1 regulates the self-renewal and oncogenesis of gastric cancer stem cells.
Wang G; Sun Q; Zhu H; Bi Y; Zhu H; Xu A
J Cell Mol Med; 2021 Jul; 25(14):6584-6601. PubMed ID: 34075691
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
32. SNAIL regulates gastric carcinogenesis through CCN3 and NEFL.
Chen R; Masuo K; Yogo A; Yokoyama S; Sugiyama A; Seno H; Yoshizawa A; Takaishi S
Carcinogenesis; 2021 Feb; 42(2):190-201. PubMed ID: 33313663
[TBL] [Abstract][Full Text] [Related]
33. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
34. Cancer Gastric Chemoprevention: Isolation of Gastric Tumor-Initiating Cells.
Mori F; Canu V; Lorenzon L; Garofalo A; Blandino G; Strano S
Methods Mol Biol; 2016; 1379():129-37. PubMed ID: 26608296
[TBL] [Abstract][Full Text] [Related]
35. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
36. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche.
Hayakawa Y; Ariyama H; Stancikova J; Sakitani K; Asfaha S; Renz BW; Dubeykovskaya ZA; Shibata W; Wang H; Westphalen CB; Chen X; Takemoto Y; Kim W; Khurana SS; Tailor Y; Nagar K; Tomita H; Hara A; Sepulveda AR; Setlik W; Gershon MD; Saha S; Ding L; Shen Z; Fox JG; Friedman RA; Konieczny SF; Worthley DL; Korinek V; Wang TC
Cancer Cell; 2015 Dec; 28(6):800-814. PubMed ID: 26585400
[TBL] [Abstract][Full Text] [Related]
37. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
38. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
39. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer.
Huang W; Wan C; Luo Q; Huang Z; Luo Q
Int J Mol Sci; 2014 Feb; 15(3):3432-43. PubMed ID: 24573253
[TBL] [Abstract][Full Text] [Related]
40. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]